相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Connective Tissue Growth Factor Is Required for Skeletal Development and Postnatal Skeletal Homeostasis in Male Mice
Ernesto Canalis et al.
ENDOCRINOLOGY (2010)
Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in Vivo
Helmut Glantschnig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Wnt Inhibitors Dkk1 and Sost Are Downstream Targets of BMP Signaling Through the Type IA Receptor (BMPRIA) in Osteoblasts
Nobuhiro Kamiya et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Two Doses of Sclerostin Antibody in Cynomolgus Monkeys Increases Bone Formation, Bone Mineral Density, and Bone Strength
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Phosphatidylinositol 3 Kinase/Akt Signal Relay Cooperates with Smad in Bone Morphogenetic Protein-2-Induced Colony Stimulating Factor-1 (CSF-1) Expression and Osteoclast Differentiation
Chandi C. Mandal et al.
ENDOCRINOLOGY (2009)
Enhanced Osteoclastogenesis Causes Osteopenia in Twisted Gastrulation-Deficient Mice Through Increased BMP Signaling
Julio E. Sotillo Rodriguez et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway
Nobuhiro Kamiya et al.
DEVELOPMENT (2008)
Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia
Anna Smerdel-Ramoya' et al.
ENDOCRINOLOGY (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2
Stefano Zanotti et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Conditional deletion of gremlin causes a transient increase in bone formation and bone mass
Elisabetta Gazzerro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Age-related changes in trabecular architecture differ in female and male C57BL/6J mice
Vaida Glatt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation
Julie B. Sneddon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development
Mina Okamoto et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass
Frederic Morvan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/β-catenin but not bone morphogenetic protein signaling
V Deregowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
C/EBP homologous protein is necessary for normal osteoblastic function
RC Pereira et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia
E Gazzerro et al.
ENDOCRINOLOGY (2005)
Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins
DG Winkler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis
O Michos et al.
DEVELOPMENT (2004)
Wnt signaling in osteoblasts and bone diseases
JJ Westendorf et al.
GENE (2004)
Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation
S Sudo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning
MK Khokha et al.
NATURE GENETICS (2003)
Skeletal overexpression of noggin results in osteopenia and reduced bone formation
RD Devlin et al.
ENDOCRINOLOGY (2003)
Bone morphogenetic proteins, their antagonists, and the skeleton
E Canalis et al.
ENDOCRINE REVIEWS (2003)
Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes
I Nazarenko et al.
NUCLEIC ACIDS RESEARCH (2002)
Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore
I Nazarenko et al.
NUCLEIC ACIDS RESEARCH (2002)
The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways
A Nohe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats
TR Nagy et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts
RC Pereira et al.
ENDOCRINOLOGY (2000)
Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin
LZ Topol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
